Skip to main content

ACR Convergence 2022 Main banner

Schedule at a Glance

Community Hub

Rheumatoid arthritis (RA)

Format: Virtual Only

591: CH RA: Management of Persistent Pain in RA

Sunday, November 13, 2022

2:15 PM – 2:45 PM Eastern Time

All of the relevant financial relationships listed for faculty have been mitigated.

Community Speaker(s)

Jonathan Kay, MD

UMass Chan Medical School
Worcester, MA, United States

Disclosure(s): AbbVie/Abbott: Consultant (Ongoing); Aker BioMarine AS: Grant/Research Support (Terminated); Alvotech Swiss AG: Consultant (Ongoing); Boehringer Ingelheim GmbH: Consultant (Ongoing); Celltrion Healthcare: Consultant (Ongoing); Fresenius Kabi: Consultant (Ongoing); Galapagos NV: Grant/Research Support (Ongoing); Inmagene LLC: Advisor or Review Panel Member (Ongoing); Jubilant Radiopharma: Consultant (Terminated); Kolon TissueGene, Inc.: Advisor or Review Panel Member (Ongoing); Novartis Pharmaceuticals Corp.: Grant/Research Support (Terminated); Organon LLC: Consultant (Ongoing); Pfizer Inc.: Consultant (Ongoing); Samsung Bioepis: Consultant (Ongoing); Sandoz Inc.: Consultant (Ongoing); Scipher Medicine: Consultant (Ongoing); Teijin Pharma Ltd.: Consultant (Ongoing)

Hub Host(s)

John Davis, III, MD, MS, RhMSUS

Mayo Clinic
Rochester, MN, United States

Disclosure information not submitted.
Katherine Liao, MD, MPH

Brigham and Women's Hospital
Boston, MA, United States

Disclosure(s): No financial relationships with ineligible companies to disclose